stars 1 stars 2 stars 3

Hugel, Inc. is a Korea-based company mainly engaged in the manufacture of biopharmaceuticals. Our product portfolio consists of botulinum toxins which are used for the treatment of benign essential blepharospasm and temporary improvement of moderate to severe glabellar lines including 50 unit types, 100 unit types and 200unit types; hyaluronic acid (HA) fillers which used for temporary removal of facial wrinkles including the chaeum premium No.1, No.2, No.3, No.4, the Chaeum MID 20A, Chaeum DEEP 20A, Chaeum SUB-Q 20A, Chaeum VOLUS 20A; Wellages, Blue Roses as well as other cosmetics. Hugel distributes its products within domestic and overseas markets.

Hugel Inc. Questions

The Hugel Inc. annual revenue was $239.43 million in 2026.

1 people are employed at Hugel Inc..

Hugel Inc. is based in Chuncheon, Gangwon.

The NAICS codes for Hugel Inc. are [3254, 32541, 32, 325].

The SIC codes for Hugel Inc. are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users